Markets

Aurobindo Pharma Q2 net rises 4% to ₹848 crore

Share of formulations in the revenue at ₹7,325 crore (₹6,640 crore) was 10.3% higher year on year

nrinewsnrinews
Nov 5, 2025 - 23:45
 0  5
Aurobindo Pharma Q2 net rises 4% to ₹848 crore
Share of formulations in the revenue at ₹7,325 crore (₹6,640 crore) was 10.3% higher year on year
Read More

Tags:

Previous Article

‘Kramnik 2.0 in the works’: Nepo lambasted for ‘complaints’ after loss

Next Article

Interior Department Pauses Plans for Layoffs Amid Shutdown

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

nrinews
nrinews

Related Posts

Adani group stocks in limelight; Adani Power surges over 19%

Adani group stocks in limelight; Adani Power surges ove...

nrinews Jan 14, 2025  0  9

Rupee hits all-time low of 92 against U.S. dollar

Rupee hits all-time low of 92 against U.S. dollar

nrinews Jan 29, 2026  0  3

Vodafone-Idea shares dip 21% as Supreme Court rejects curative petition on AGR dues 

Vodafone-Idea shares dip 21% as Supreme Court rejects c...

nrinews Sep 19, 2024  0  14